Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Equity Average (2016 - 2025)

Editas Medicine (EDIT) has disclosed Equity Average for 10 consecutive years, with $16.3 million as the latest value for Q3 2025.

  • Quarterly Equity Average fell 91.99% to $16.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Sep 2025, down 91.99% year-over-year, with the annual reading at $241.7 million for FY2024, 31.9% down from the prior year.
  • Equity Average for Q3 2025 was $16.3 million at Editas Medicine, down from $40.8 million in the prior quarter.
  • The five-year high for Equity Average was $625.7 million in Q2 2021, with the low at $16.3 million in Q3 2025.
  • Average Equity Average over 5 years is $352.3 million, with a median of $358.7 million recorded in 2023.
  • The sharpest move saw Equity Average surged 107.56% in 2021, then tumbled 91.99% in 2025.
  • Over 5 years, Equity Average stood at $570.2 million in 2021, then plummeted by 32.01% to $387.7 million in 2022, then fell by 8.49% to $354.8 million in 2023, then tumbled by 56.32% to $155.0 million in 2024, then tumbled by 89.47% to $16.3 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $16.3 million, $40.8 million, and $98.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.